Jonathan Dworkin, PhD, professor of microbiology & immunology at the Vagelos College of Physicians and Surgeons, has been named a fellow of the American Association for the Advancement of Science.
New details about the way this important molecule takes on tasks beyond sensing calcium could spur the develop of new drugs for breast cancer and other diseases.
BeatProfiler, a new research tool invented by Columbia bioengineers with the help of AI, speeds and simplifies the analysis of engineered heart tissue in the laboratory.
Columbia microbiologists have found that commensal gut bacteria induce their host to generate T cells that prevent inflammation and maintain the health of the gut.
A clinical trial based on discoveries made by researchers in Columbia’s Pancreas Center is showing promising results and is now expanding to include more patients.
Smell’s sensory magic emerges from an intricate developmental mechanism that tailors each of the nose’s sensory cells to detect a specific odor chemical.
Sara Zaccara took a risk as a postdoc when she jumped into the new field of epitranscriptomics, but her discoveries have paid off and are now being tested in patients.
A new study is helping to clarify how low-grade lymphoma changes as it develops into a more aggressive tumor, which could lead to the development of new treatments.
An expanding artificial heart valve being developed by Columbia surgeons and engineers could simplify treatment for many kids born with congenital heart disease.
Columbia researchers discovered stem cells in mice that are essential in maintaining healthy cartilage inside joints, but the cells go missing with age or after injury.
Many Black Americans thought to have a high risk of developing kidney disease possess a genetic variant that eradicates the extra risk, a new study from Columbia researchers has found.
Immunotherapy has been disappointing as treatment for prostate cancer, but a new Columbia trial suggests it has potential for treating metastatic disease.
Columbia physicians and patients were essential in demonstrating the effectiveness of the world’s first CRISPR gene-editing therapy, now approved for use in the United States.